When designing your next generation medical device, a crucial step in the early stages of the process is selecting materials with the appropriate biocompatibility and biostability profiles. In simple terms, biocompatibility is the effect of a material on its host, while biostability is the effect of the host on the material. As partners in the device development process, we not only help guide you through the biocompatibility and biostability selection process, but also serve as a collaborative partner throughout the entire journey, giving you better control over the process of bringing that device to market. At Lubrizol, our goal is delivering value beyond the device.
Biocompatibility and biostability are two properties in the material selection process that are important, but sometimes misunderstood. This introduction defines these terms, explains why they both matter to patient health, and provides examples of how performance properties of commonly used polymers determine what devices in which they may successfully be used.
In this short video, learn about hemocompatibility, the importance of biocompatible polymers to the material selection process, and the impact on device performance compared to that of a non-biocompatible polymer.
To help ensure better patient outcomes and minimize risks related to biocompatibility and biostability when designing your medical device, this overview provides seven key application-specific factors to consider during the material selection phase of development.
For medical devices, successful patient outcomes are the key metric for success. That’s why the biocompatibility evaluation process can be a rigorous one. In this overview, our experts provide key testing standards and data used in the biocompatibility assessment process before the device is submitted to the appropriate governing regulatory agency.